Showing 2191-2200 of 2527 results for "".
- Scientists Rescue ‘Mini Retinas’ From Eye Disease Via New Gene Therapy Approachhttps://modernod.com/news/scientists-rescue-mini-retinas-from-eye-disease-via-new-gene-therapy-approach/2477895/Scientists have developed a new gene therapy approach that offers promise for one day treating retinitis pigmentosa, according to Trinity College Dublin. Researchers from Trinity College and University College London (UCL) teamed up to pool their expertise in ge
- AstraZeneca to Supply Europe Up to 400 Million COVID-19 Vaccine Doseshttps://modernod.com/news/astrazeneca-to-supply-europe-up-to-400-million-covid-19-vaccine-doses/2479514/AstraZeneca announced that it has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the University of Oxford’s COVID-19 experimental vaccine, with deliveries starting by the end of this year. CEO Pascal Soriot remarked that ̶
- AORN Releases Survey Results Exploring ORs’ Return to Pre-COVID-19 Surgical Volumeshttps://modernod.com/news/aorn-releases-survey-results-exploring-ors-return-to-pre-covid-19-surgical-volumes/2479521/The Association of periOperative Registered Nurses (AORN) announced survey results of more than 1,000 surgical nurse leaders in the United States regarding how their facilities are managing the resumption of elective surgeries. Key Findings The top three spec
- US States Sue 26 Generic Drugmakers for Alleged Price Fixinghttps://modernod.com/news/us-states-sue-26-generic-drugmakers-for-alleged-price-fixing/2479522/A coalition of 51 US states and territories filed a lawsuit in federal court in Connecticut on Wednesday, accusing 26 drug companies, including Taro, Perrigo, Novartis’ Sandoz unit, Actavis, Mylan, Teva, G&W and Glenmark, of conspiring to fix prices and allocate markets for at least 80
- Some Biologics May Be Better Than Others for Averting Anterior Uveitishttps://modernod.com/news/some-biologics-may-be-better-than-others-for-averting-anterior-uveitis/2477890/Among patients with ankylosing spondylitis or undifferentiated spondyloarthritis, risk for anterior uveitis may hinge on the choice of biologic disease-modifying antirheumatic drug (bDMARD), a large Swedish cohort study suggests, according to a Medscape
- Study: Vision Loss Influences Perception of Soundhttps://modernod.com/news/study-vision-loss-influences-perception-of-sound/2477884/People with severe vision loss can less accurately judge the distance of nearby sounds, potentially putting them more at risk of injury, according to new research published in the journal Scientific Reports. Researchers from Anglia Ruskin University’s Vision and Eye Research Insti
- Zeiss Announces 3 Million Eyes Treated With SMILEhttps://modernod.com/news/zeiss-announces-3-million-eyes-treated-with-smile/2477881/Zeiss Medical Technology announced a new milestone with more than 3 million treated eyes with SMILE in more than 1,000 clinics worldwide. SMILE, which became commercially available in the United States in 2017, is a minimally-invasive corneal refractive procedure performed by using the Vi
- Oxford Biomedica Snags Manufacturing Equipment to Ramp Up Production of COVID-19 Vaccinehttps://modernod.com/news/oxford-biomedica-snags-manufacturing-equipment-to-ramp-up-production-of-covid-19-vaccine/2477880/In the race for a COVID-19 vaccine, the University of Oxford has stormed to an early lead with the commercial manufacturing support of British drugmaker AstraZeneca. Now, in an effort to scale up capacity for global demand, one of AstraZeneca’s manufacturing partners has struck a deal for n
- Implandata Launches Eyemate IOP-Tracking Service for Remote Monitoring and Improved Glaucoma Carehttps://modernod.com/news/implandata-launches-eyemate-iop-tracking-service-for-remote-monitoring-and-improved-glaucoma-care/2477870/Implandata Ophthalmic Products announced the launch of its web-based Eyemate IOP-Tracking Service for remote monitoring and management of glaucoma. The Eyemate provides eye doctors with IOP measurements collected anytime under patients’ normal life conditions. “Remote IOP monitoring provid
- AbbVie Enters Deal to Develop Antibody Therapeutic for COVID-19https://modernod.com/news/abbvie-enters-deal-to-develop-antibody-therapeutic-for-covid-19/2477869/AbbVie entered into a collaboration with Harbour BioMed, Utrecht University, and Erasmus Medical Center to develop an antibody therapeutic to prevent and treat COVID-19, the parties announced Friday. The fully human, neutralising antibody 47D11, which targets the conserved domain of the spike pro